Comparison of two triphasic contraceptives with different progestogens: Effects on metabolism and coagulation proteins

Contraception

Volumn 41, Issue 4, 1990, Pages 363-376

  Ball, M J ^b   Ashwell, E ^a   Jackson, M ^a   Gillmer, M D G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTODENE; HIGH DENSITY LIPOPROTEIN; LEVONORGESTREL; LOW DENSITY LIPOPROTEIN; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTITHROMBIN III; BLOOD COAGULATION FACTORS; BLOOD PRESSURE; BODY WEIGHT; CARBOHYDRATES; CONTRACEPTIVES, ORAL, HORMONAL; FACTOR VII; FEMALE; FIBRINOGEN; HUMAN; LIPIDS; NORGESTREL; NORPREGNENES; SEX HORMONE-BINDING GLOBULIN;

EID: 0025228398     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(90)90036-U     Document Type: Article

References (46)

1. 1 oral contraception study
2. Mortality among women participating in the Oxford/Family Planning Association contraceptive study
3. High density lipoproteins Epidemiologic profile and risks of coronary heart disease
4. The triglyceride issue, A view from Framingham
5. Female hormones and vascular disease: an epidemiologic overview
6. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives
7. Oral contraceptives and death from myocardial infarction
8. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 30μg and 50g oestrogen preparations
9. Comparison of effects of different combined oral contraceptive formulations on carbohydrate and lipid metabolism
10. Oral contraceptives, clotting factors and thrombosis
11. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol
12. Lipid metabolic studies in oophorectomized women Effects of three different progestogens
13. Oral contraceptives and postmenopausal estrogen effects on lipoprotein triglycerides and cholesterol in an adult female population
14. Endocrine pharmacological profile of gestodene
15. Improved reagent for the enzymatic determination of serum cholesterol
16. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
17. Lipoprotein fractionation by a precipitation method
18. Determination of glucose in blood using glucose oxidase
19. A semi-automated method for the determination of glycosylated haemoglobin
20. The study of steroid protein binding by novel “two-tier” column employing Cibacron Blue S 3G-A-Sepharose 4B I Sex Hormone Binding Globulin
21. Gerinhungsphysiologische schnellmethode zur bestimmung des fibrinogens
22. Heparin co-factor actually measured with an amidolytic method
23. Oral contraceptives, lipids and cardiovascular disease
24. Epidemiology as a guide to clinical decisions: Association between triglyceride and coronary heart disease
25. Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins
26. A metabolic assessment of different oral contraceptives
27. Effects of seven low-dose combined oral contraceptives on high density lipoprotein subfractions
28. High density lipoprotein 2 and hepatic lipase
29. The effect of two gonone progestins alone and in combination with ethinyl estradiol on serum lipoproteins
30. Lipoprotein changes may be minimised by proper composition of a combined oral contraceptive
31. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene
32. Multiple risk factor intervention trial Risk factor changes and mortality results
33. Comparative data on the effects of low-dose oral contraceptives on coagulation
34. Platelet and coagulation functions during triphasic oestrogen-progesterone treatment
35. A comparison of the effects of two triphasic oral contraceptives on haemostasis
36. Oral contraceptives and blood coagulation: A critical review
37. Oral contraceptives, blood clotting and thrombosis
38. Haemostatic system changes induced by 50μg and 30μg estrogen/progestogen oral contraceptives
39. Haemostatic function and ischaemic heart disease principle results of the Northwick Park heart study
40. Serum steroid binding protein concentrations, distribution of progestogens and bioavailability of testosterone during treatment with oral contraceptives containing desogestrel or levonorgestrel
41. The use of plasma proteins as indicators of the metabolic effects of combined oral contraceptives
42. Effect of combined oral contraceptives on glycosylated haemoglobin
43. Urinary excretion of different corticosteroid metabolites in oral contraception and pregnancy
44. Prospective studies of carbohydrate metabolism in “normal” women using norgestrel for 18 months